Sculptra In NYC by a Board-Certified Dermatologist
Gradually Restore and Revitalize with Treatments on Manhattan's Upper East Side.
Why Sculptra Is Different from Every Other Injectable
A Biostimulator That Rebuilds What Time Has Taken
Medically reviewed by Arash Akhavan, MD, FAAD | Board-Certified Dermatologist | Founder, The Dermatology and Laser Group, New York City | Faculty, Mount Sinai Department of Dermatology
Last Medically Reviewed: March 14, 2026
Sculptra is not a filler — and that distinction matters more than most patients realize. While traditional dermal fillers like Juvederm and Restylane add temporary volume by injecting hyaluronic acid gel beneath the skin, Sculptra works by stimulating your body's own collagen production, gradually rebuilding the structural foundation that aging, weight loss, and gravity have diminished. The result is not an overnight change, but a steady, natural-looking restoration that unfolds over weeks and months — and lasts far longer than any conventional filler.
At The Dermatology and Laser Group, Dr. Arash Akhavan personally administers every Sculptra treatment in our private Upper East Side office. As a nationally recognized cosmetic dermatologist in NYC and one of a very select few physicians in the country chosen to serve as a faculty trainer for two major injectable manufacturers, Arash Akhavan, MD has spent over a decade refining injection techniques that prioritize subtlety, patient safety, and long-term results over dramatic, detectable changes. A Castle Connolly Top Doctor for over 13 consecutive years, NY Magazine Top Doctor, and NY Times-listed Super Doctor with hundreds of five-star patient reviews, Dr. Arash Akhavan's philosophy with Sculptra is simple: take it slow, stay conservative, and let the collagen do the work.
As Featured In:
Over 300 media appearances as a national expert in cosmetic dermatology and body contouring.
The Science Behind Collagen Biostimulation
Sculptra Aesthetic is an FDA-approved injectable formulated with poly-L-lactic acid (PLLA), a biocompatible, biodegradable synthetic substance that has been safely used in dissolvable medical sutures for decades. When injected into the deep dermis, PLLA microparticles trigger a controlled sub-dermal inflammatory response — activating macrophages and fibroblasts through the TGF-β signaling pathway — that stimulates your body's natural fibroblasts to produce new type I collagen.
This mechanism is fundamentally different from hyaluronic acid fillers. Where Juvederm or Restylane act as a gel-like placeholder that adds immediate but temporary volume, Sculptra addresses the underlying structural cause of facial aging: the progressive loss of collagen that begins in our mid-twenties and accelerates each decade. Fibroblast proliferation reaches its peak approximately six months after injection, which is why Sculptra results develop gradually — and why patients often describe the outcome as looking like they simply "turned back the clock" rather than having had any work done.
Sculptra was first granted FDA approval on August 3, 2004, for restoration of facial fat loss in patients with HIV. On July 28, 2009, the FDA expanded approval to aesthetic indications — specifically the correction of shallow-to-deep nasolabial fold contour deficiencies and facial wrinkles. Most recently, in April 2023, Galderma received FDA approval for Sculptra to correct fine lines and wrinkles in the cheek area, with clinical efficacy data showing 96% improvement at three months and 94% improvement sustained at two years.
“One thing I always tell my Sculptra patients during the consultation is that this is an investment in your skin’s future, not just a quick fix for today,” says Dr. Arash Akhavan, a board-certified dermatologist and Assistant Clinical Professor at Mount Sinai’s Department of Dermatology. “The collagen your body builds after Sculptra treatment becomes part of your own tissue — it’s yours to keep.”
Addressing "Ozempic Face" and GLP-1 Weight Loss Facial Hollowing
The widespread adoption of GLP-1 receptor agonist medications — including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — has created one of the most rapidly growing patient concerns in cosmetic dermatology: medication-driven facial volume loss, colloquially known as “Ozempic Face.” While these medications are remarkably effective for weight management and metabolic health, the rapid fat loss they produce does not discriminate — facial fat pads that provide youthful structure to the temples, cheeks, and jawline are depleted alongside body fat, often leaving patients with a hollow, aged appearance that contradicts the healthier physique they’ve worked to achieve.
Sculptra is uniquely suited to address this specific clinical challenge. Unlike hyaluronic acid fillers that temporarily mask volume loss with an external substance, Sculptra stimulates the regeneration of the patient’s own collagen and structural tissue — effectively rebuilding what the medication has diminished. A landmark Phase IV clinical trial conducted by Galderma across two U.S. sites demonstrated that a treatment protocol combining Sculptra with hyaluronic acid filler for GLP-1-related facial volume loss achieved a 91.4% patient recommendation rate, with significant improvements in both skin radiance and facial contour sustained through nine months of follow-up.
Research from this trial also revealed that Sculptra stimulates adipocyte-derived stem cells — the very cells that GLP-1 medications may be inhibiting — increasing collagen, elastin, and hyaluronic acid production through fibroblast differentiation. For patients on these medications who are experiencing noticeable facial hollowing, Dr. Arash Akhavan develops individualized treatment plans that typically begin with a series of Sculptra sessions to rebuild the structural collagen foundation, with the option of targeted hyaluronic acid filler placement for fine-tuning specific areas once the biostimulatory process is underway.
“I’ve seen a significant increase in patients coming in specifically because they love how they feel after losing weight on their GLP-1 medication, but they don’t recognize their own face anymore,” says Arash Akhavan, MD, FAAD. “Sculptra is ideal for these patients because we’re not just filling — we’re regenerating the collagen architecture their face has lost. And we take a very conservative, gradual approach so the results look completely natural.”
While predominantly known for its transformative effects on facial hollowing, Sculptra’s potent collagen-stimulating combine with fat-stimulating properties to make it the premier choice for non-surgical body contouring, including the highly sought-after Sculptra Butt Lift.
Facial Treatment Areas and the Ideal Candidate
Sculptra is most effective for restoring volume and stimulating collagen in areas of the face where structural fat loss and skin laxity are most visible. At The Dermatology and Laser Group, Dr. Arash Akhavan commonly treats the following areas during Sculptra sessions in our Manhattan office:
- Temples: One of the earliest areas to show age-related hollowing, particularly in patients with lean facial structures or those who have experienced weight loss. Sculptra rebuilds volume in the temporal region by stimulating collagen directly beneath the skin, creating a thicker, more resilient tissue layer.
- Mid-Cheeks: Sculptra restores the natural fullness of the malar and submalar fat pads that deflate over time, lifting the midface and reducing the “tired” appearance that hollowed cheeks create.
- Nasolabial Folds: The FDA-approved primary aesthetic indication — Sculptra softens the deep creases running from the nose to the corners of the mouth by rebuilding collagen in the surrounding tissue.
- Marionette Lines: The lines extending downward from the corners of the mouth respond well to Sculptra’s gradual volumizing effect, reducing the appearance of a downturned or “sad” expression.
Areas Sculptra Should Not Be Used: Sculptra is not recommended for injection into the lips (the vermillion border and lip body), the periorbital area (under the eyes), or the forehead. The skin in these areas is thinner and more mobile, which increases the risk of visible nodule formation. For lip augmentation, Dr. Akhavan recommends hyaluronic acid fillers such as Revanesse Lips+, Restylane Kysses, or RHA, which are specifically designed for that anatomy.
Who May Not Be a Candidate: Sculptra is not recommended for patients who are pregnant, have active skin infections or inflammation in the treatment area, have a known allergy to poly-L-lactic acid (PLLA), carboxymethylcellulose, or nonpyrogenic mannitol, or who have a history of hypertrophic scarring or keloid formation. Patients using blood-thinning medications should discuss this with Dr. Akhavan during the consultation, as they may have an increased risk of bruising at the injection site.
Sculptra Before and After Images
Sculptra NYC Pricing
Your Investment in Collagen Restoration
Sculptra at The Dermatology and Laser Group is $950 per vial. Because Sculptra works through gradual collagen stimulation rather than immediate volume replacement, most patients require a series of treatment sessions to achieve their desired result. The number of vials and sessions depends on several factors — the degree of volume loss, the number of facial areas being treated, the patient’s age, and their individual aesthetic goals.
A general guideline used by experienced injectors is approximately one vial per decade of age, distributed across multiple sessions. For example, a patient in her 40s may benefit from approximately four vials total, typically administered as one to two vials per session across two to three appointments spaced four to six weeks apart. Patients seeking subtle enhancement may require fewer vials, while those addressing more significant volume loss — particularly from rapid weight loss or “Ozempic Face” — may benefit from a more comprehensive protocol.
It’s important to consider that Sculptra results last two years or longer — significantly longer than traditional fillers that typically require retreatment every twelve months. When calculated on a per-month basis, Sculptra often represents greater long-term value.
Dr. Arash Akhavan develops a personalized treatment plan during every consultation, including a realistic estimate of the number of vials and sessions needed to achieve your goals. There is no pressure to commit to a full series — many patients prefer to start with a single session and assess their collagen response before continuing.
Patient Testimonials and Reviews
Comparing Sculptra to Traditional Dermal Fillers
Patients researching injectable treatments in New York City often weigh Sculptra against hyaluronic acid fillers and other volumizers. The key clinical distinction is mechanism: Sculptra stimulates your body’s own collagen production over time, while traditional fillers add immediate but temporary volume with an external substance. The table below provides a factual comparison of the most commonly used injectables for facial volume restoration.
| Feature | Sculptra | Juvederm | Radiesse | Restylane |
|---|---|---|---|---|
| Active Ingredient | Poly-L-lactic acid | Hyaluronic acid | Calcium hydroxyapatite | Hyaluronic acid |
| Mechanism | Collagen + fat stimulation | Volume replacement | Collagen stimulation | Volume replacement |
| Results Onset | Gradual (weeks) | Immediate | Gradual (weeks) | Immediate |
| Duration | 2+ years | 6–18 months | ~18 months | 6–12 months |
| Reversible | No | Yes (hyaluronidase) | No | Yes (hyaluronidase) |
| Sessions Needed | 2–3 sessions | 1 session | 1–2 sessions | 1 session |
| Best For | Global volume loss | Lips, cheeks, lines | Deep folds, jawline | Fine lines, lips |
| Skin Quality Benefit | Yes (Sculptra Glow) | Hydration only | Yes | Hydration only |
Sculptra FAQ
The 5-5-5 rule — also called the Rule of Fives — is the standard post-treatment massage protocol for Sculptra. It involves massaging the treated areas for five minutes, five times per day, for five consecutive days following your injection session. This massage ensures even distribution of the PLLA particles beneath the skin, promotes uniform collagen stimulation across the treated area, and helps prevent the formation of small nodules or lumps. Dr. Arash Akhavan reviews the proper massage technique with every patient before they leave the office and provides detailed aftercare instructions.
For patients seeking long-lasting, natural-looking facial volume restoration, Sculptra consistently delivers exceptional value. Unlike hyaluronic acid fillers that typically last six to twelve months, Sculptra results last two years or longer — with clinical data showing 80% of patients still satisfied with their results at 25 months. The gradual improvement also means results look natural rather than “done,” which is particularly important for our Manhattan patients who value discretion. Additionally, the “Sculptra Glow” — measurable improvements in skin radiance and firmness — provides benefits beyond volume restoration alone.
Sculptra results typically last two to three years. Because the treatment works by stimulating your body’s own collagen production, the timeline for seeing results is gradual: most patients notice subtle improvements within one month, with collagen production peaking between four and six months after the final treatment session. Once the collagen has fully matured, the structural improvements remain as your own natural tissue. Annual maintenance treatments can extend and sustain results indefinitely.
Yes. Sculptra was first FDA approved on August 3, 2004, for restoration of facial fat loss in patients with HIV. On July 28, 2009, the FDA expanded approval to aesthetic indications — specifically the correction of shallow-to-deep nasolabial fold contour deficiencies and facial wrinkles. Most recently, in April 2023, Sculptra received additional FDA approval for treatment of fine lines and wrinkles in the cheek area. Sculptra is manufactured by Galderma, one of the world’s largest dermatology companies.
Sculptra is one of the most effective treatments available for facial volume loss caused by GLP-1 receptor agonist medications like Ozempic, Wegovy, and Mounjaro. A Phase IV clinical trial by Galderma demonstrated that a Sculptra-based treatment protocol for GLP-1-related facial volume loss achieved a 91.4% patient recommendation rate with sustained improvements through nine months. Because Sculptra stimulates your own collagen production rather than simply adding temporary filler material, it rebuilds the structural foundation that rapid weight loss has diminished. Dr. Arash Akhavan has seen a significant increase in patients seeking Sculptra specifically for this concern and develops individualized conservative treatment plans for each patient.
The fundamental difference is mechanism. Juvederm, Restylane, and other hyaluronic acid fillers work by injecting a gel substance that immediately adds volume beneath the skin — but that volume is temporary and gradually absorbed by your body over six to twelve months. Sculptra contains poly-L-lactic acid (PLLA), which stimulates your body’s own fibroblasts to produce new collagen over the course of several months. The result is your own natural tissue rather than an external substance, which is why Sculptra results last two years or longer and look exceptionally natural.
The PLLA microparticles in Sculptra are biodegradable and are gradually metabolized by your body over approximately 18 to 24 months — this is by design, as the particles have already triggered collagen production well before they dissolve. However, unlike hyaluronic acid fillers that can be dissolved with hyaluronidase in a matter of hours, Sculptra cannot be chemically reversed. This is why Dr. Akhavan emphasizes a conservative, gradual treatment approach — starting with fewer vials and building over multiple sessions — to ensure the result develops naturally and predictably.
The number of vials varies based on your degree of volume loss, the areas being treated, and your aesthetic goals. A commonly used guideline is approximately one vial per decade of age, distributed across two to three treatment sessions spaced four to six weeks apart. Most patients at The Dermatology and Laser Group receive between two and four vials total for facial rejuvenation, though patients addressing significant volume loss — especially from weight loss or aging — may benefit from additional vials. Dr. Arash Akhavan provides a personalized estimate during your consultation.
The most common side effects are injection-site reactions: temporary swelling, redness, tenderness, and bruising that typically resolve within two to five days. A small percentage of patients — between 0.02% and 1% — may develop subcutaneous nodules or granulomas, which are small lumps that can appear six to twelve months after treatment. Following the 5-5-5 massage protocol, receiving treatment from an experienced board-certified dermatologist, and using conservative volumes per session significantly reduce this risk. Dr. Akhavan discusses all potential side effects and risks during the consultation so every patient can make a fully informed decision.
The Sculptra Glow refers to measurable improvements in skin quality — including radiance, firmness, and overall texture — that result from the collagen stimulation process. This goes beyond volume restoration; as new collagen fibers form beneath the skin, the skin itself becomes thicker, more resilient, and more luminous. Clinical data published by Galderma shows that 95% of patients demonstrated improved skin glow two years after Sculptra treatment. It is the first FDA-approved dermal filler verified to improve both skin firmness and radiance — benefits that no hyaluronic acid filler provides.
A Private Manhattan Address for Facial Rejuvenation
The Dermatology and Laser Group is located at 110 East 60th Street, in the heart of Manhattan's Upper East Side — one of the most sought-after neighborhoods for premium medical aesthetics in New York City. Our private, luxury office is steps from Park Avenue and easily accessible from Lenox Hill, Sutton Place, Midtown East, and Central Park South. Whether you're coming from a nearby office in Midtown or traveling from Brooklyn, the Upper West Side, or the greater tri-state area, our discreet location offers the ideal setting for your Sculptra consultation and treatment with Dr. Arash Akhavan.
You May Also Be Interested In:
Tattoo Removal
We have been one of the most popular places for tattoo removal in NYC for over a decade.
Arash Akhavan, MD is founder and owner of The Dermatology and Laser Group, one of the top centers for cosmetic procedures in New York City for over a decade. Arash Akhavan, MD, FAAD is a Board Certified Dermatologist and an Associate Professor at The Mount Sinai School of Medicine. Dr. Akhavan is a Castle Connolly Top Doc, New York Magazine Best Doctor, and Super Doctor featured in The New York Times. Dr. Akhavan is a key opinion leader that has been featured on hundreds of media publications including The New York Times, Allure, Marie Claire, Women’s Health, Cosmopolitan, ABC News, Fox News, Fox 5, NY1, WPIX, and more. He has been featured on nationally syndicated television programs such as The Doctors.
Dr. Akhavan serves as an educator and lecturer for multiple aesthetic device and injectable companies. This allows his office access to newer technologies at an earlier date than other offices, as well as a higher level of expertise in the use of these devices. This, in turn, translates to more effective and safer treatments for our patients.